The rising global cancer burden continues to drive market expansion, with WHO reporting 20 million new cases and 9.7 million deaths in 2022, marking a sustained surge driven by aging populations, ...
The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...
TipRanks on MSN
Kazia Therapeutics Secures $50 Million in Private Placement to Advance Cancer Drug Development
An update from Kazia Therapeutics ( ($KZIA) ) is now available. On December 2, 2025, Kazia Therapeutics announced a $50 million private placement ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
FDA proposals include ‘major updates’ to simplify biosimilarity studies, reduce unnecessary clinical testing, and ease the ...
This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways Extending their collaboration, Genialis and Debiopharm continue working towards a ...
Joshua Branson will be joined by friends and family for the relay. Participants will run from Shelbyville to Knoxville ...
Researchers have identified a stress-activated control mechanism that helps breast cancer cells reshape gene activity to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback